Why Is Methylphenidate the First-Line Choice for Child ADHD? — 133-RCT Network Meta-Analysis (2018)

Target: Children, adolescents, and adults with ADHD (133 RCTs) Type: NetworkMetaAnalysis Grade: A

3-Line Summary

What: Compared efficacy and tolerability of ADHD medications across 133 RCTs using a network meta-analysis.
Who: Analyzed children/adolescents and adults separately to evaluate drug-specific effects and side effects.
Result: Methylphenidate was supported as the first-line choice for children and adolescents.

Keywords

methylphenidate first-line network-meta-analysis efficacy tolerability

Action Tips

You can ask the specialist why this particular medication was chosen.
Drug effects and side effects vary by individual, so maintain regular follow-ups.